ABBOTT LABORATORIES Significant (Increase) Decrease in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Upper Bound (Deprecated 2015-01-31)
ABBOTT LABORATORIES (ABT) had Significant (Increase) Decrease in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Upper Bound (Deprecated 2015-01-31) of $635.00 million as of 2015-09-30, per its 10-Q filed 2015-11-05.
Discontinued › Notes › Income Taxes
us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleEstimatedRangeOfChangeUpperBound · last filed 2015-11-05
- 2015-09-30: Significant (Increase) Decrease in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Upper Bound (Deprecated 2015-01-31) $635.00M.
- 2015-06-30: Significant (Increase) Decrease in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Upper Bound (Deprecated 2015-01-31) $635.00M.
- 2015-03-31: Significant (Increase) Decrease in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Upper Bound (Deprecated 2015-01-31) $635.00M.
- 2014-12-31: Significant (Increase) Decrease in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Upper Bound (Deprecated 2015-01-31) $635.00M.
| Period end | Significant (Increase) Decrease in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Upper Bound (Deprecated 2015-01-31) |
|---|---|
| 2015-09-30 | $635.00M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $635.00M 10-Q · filed 2015-08-04 |
| 2015-03-31 | $635.00M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $635.00M 10-K · filed 2015-02-27 |
| 2013-12-31 | $425.00M 10-K · filed 2014-02-21 |
| 2013-09-30 | $450.00M 10-Q · filed 2013-11-07 |
| 2013-06-30 | -$650.00M 10-Q · filed 2013-08-06 |
| 2013-03-31 | -$650.00M 10-Q · filed 2013-05-08 |
| 2012-07-31 | $350.00M 10-Q · filed 2012-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |